File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3969/j.issn.1674-8115.2019.06.019
- Scopus: eid_2-s2.0-85070881450
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Alterations in bile acid levels in metabolic diseases and related treatment strategies
Title | Alterations in bile acid levels in metabolic diseases and related treatment strategies |
---|---|
Authors | |
Keywords | Bile acid Biomarker Farnesoid X receptor (FXR) G-protein-coupled bile acid receptor 1 Metabolic disease |
Issue Date | 2019 |
Citation | Journal of Shanghai Jiaotong University (Medical Science), 2019, v. 39, n. 6, p. 678-683 How to Cite? |
Abstract | Bile acid as a signaling molecule can specifically bind to bile acid receptors (such as farnesoid X receptor and G-protein-coupled bile acid receptor) to mediate a series of biological regulation reactions. In recent years, it has been found that bile acids are widely involved in glucose metabolism, lipid metabolism and energy metabolism. The development of metabolic diseases is usually accompanied by the changes of bile acid profiles and receptors, and thus bile acids may be applied as potential biomarkers for clinical diagnosis, prediction, and evaluation of therapeutic effects. This article reviews the relationship between bile acids and metabolic diseases, and the treatment of metabolic diseases based on the regulation of bile acid metabolism. |
Persistent Identifier | http://hdl.handle.net/10722/342591 |
ISSN | 2023 SCImago Journal Rankings: 0.110 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kuang, Jun Liang | - |
dc.contributor.author | Zheng, Xiao Jiao | - |
dc.contributor.author | Zhao, Ai Hua | - |
dc.contributor.author | Jia, Wei | - |
dc.date.accessioned | 2024-04-17T07:04:53Z | - |
dc.date.available | 2024-04-17T07:04:53Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Journal of Shanghai Jiaotong University (Medical Science), 2019, v. 39, n. 6, p. 678-683 | - |
dc.identifier.issn | 1674-8115 | - |
dc.identifier.uri | http://hdl.handle.net/10722/342591 | - |
dc.description.abstract | Bile acid as a signaling molecule can specifically bind to bile acid receptors (such as farnesoid X receptor and G-protein-coupled bile acid receptor) to mediate a series of biological regulation reactions. In recent years, it has been found that bile acids are widely involved in glucose metabolism, lipid metabolism and energy metabolism. The development of metabolic diseases is usually accompanied by the changes of bile acid profiles and receptors, and thus bile acids may be applied as potential biomarkers for clinical diagnosis, prediction, and evaluation of therapeutic effects. This article reviews the relationship between bile acids and metabolic diseases, and the treatment of metabolic diseases based on the regulation of bile acid metabolism. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Shanghai Jiaotong University (Medical Science) | - |
dc.subject | Bile acid | - |
dc.subject | Biomarker | - |
dc.subject | Farnesoid X receptor (FXR) | - |
dc.subject | G-protein-coupled bile acid receptor 1 | - |
dc.subject | Metabolic disease | - |
dc.title | Alterations in bile acid levels in metabolic diseases and related treatment strategies | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.3969/j.issn.1674-8115.2019.06.019 | - |
dc.identifier.scopus | eid_2-s2.0-85070881450 | - |
dc.identifier.volume | 39 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 678 | - |
dc.identifier.epage | 683 | - |